Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-20-261377
Filing Date
2020-10-01
Accepted
2020-10-01 16:41:29
Documents
2
Group Members
VIDA VENTURES II-A, LLCVV MANAGER II, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d14661dsc13d.htm SC 13D 74408
2 EX-99.1 d14661dex991.htm EX-99.1 5348
  Complete submission text file 0001193125-20-261377.txt   81256
Mailing Address 40 BROAD STREET, SUITE 201 BOSTON MA 02109
Business Address 40 BROAD STREET, SUITE 201 BOSTON MA 02109 857-254-9492
Vida Ventures II, LLC (Filed by) CIK: 0001776851 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Subject) CIK: 0001818794 (see all company filings)

EIN.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91706 | Film No.: 201216701
SIC: 2834 Pharmaceutical Preparations